ArticleMolecular cancer therapeutics2007

Rapamycin inhibits multiple stages of c-Neu/ErbB2 induced tumor progression in a transgenic mouse model of HER2-positive breast cancer.

Jonathan D Mosley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.